냉동 절제 프로브 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Cryoablation Probe Market Summary

The global cryoablation probe market size was estimated at USD 189.80 million in 2024 and is projected to reach USD 646.84 million by 2033, growing at a CAGR of 14.69% from 2025 to 2033. The market's growth is attributed to the rising incidence of cancers such as prostate, liver, kidney, and lung, which increases the demand for effective, minimally invasive treatments.

Cryoablation is becoming a preferred option among patients and healthcare providers because it offers shorter recovery times, fewer complications, and better cosmetic results compared to traditional surgery. In addition, continuous advancements in probe design, imaging technologies like CT and MRI guidance, and improved cryogen control systems enhance the procedure's precision and safety, further supporting its widespread adoption in clinical settings.

The rising incidence of cancers, particularly prostate, liver, kidney, and lung, has become a key driver for the growing demand for cryoablation probes, as these cancers are often treatable with localized, minimally invasive techniques. With the global cancer burden increasing, there is a greater need for treatment options that are effective, safe, and less physically taxing, especially for patients who may not be suitable for traditional surgery due to age, other health conditions, or advanced disease stages. Cryoablation addresses this need by enabling precise targeting and destruction of cancerous tissue using extreme cold, while minimizing damage to surrounding healthy areas. These advantages make cryoablation an increasingly preferred option, fueling the demand for probes in such procedures.

Global Cryoablation Probe Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cryoablation probe market report based onapplication, end use, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiac Arrhythmias
• Oncology
  • Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Kidney Cancer
  • Liver Cancer
• Dermatology
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers (ASCs)
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
• 1.15. Approach 1: Commodity flow approach
• 1.16. Volume price analysis (Model 2)
• 1.17. Approach 2: Volume price analysis
• 1.18. List of Secondary Sources
• 1.19. List of Primary Sources
• 1.20. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cryoablation Probe Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising cancer incidence
    • 3.2.1.2. Growing preference for minimally invasive procedures
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunities Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Cryoablation Probe Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
  • 3.3.3. COVID-19 Impact Analysis
    • 3.3.3.1. Disrupted Breast Pump
    • 3.3.3.2. Obstacles in Breast Pump

Chapter 4. Cryoablation Probe Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Cryoablation Probe Market: Application Movement Analysis & Market Share, 2024 & 2030
• 4.3. Cardiac Arrhythmias
  • 4.3.1. Cardiac Arrhythmias Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Oncology
  • 4.4.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Lung Cancer
    • 4.4.2.1. Lung Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Prostate Cancer
    • 4.4.3.1. Prostate Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Breast Cancer
    • 4.4.4.1. Breast Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Kidney Cancer
    • 4.4.5.1. Kidney Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Liver Cancer
    • 4.4.6.1. Liver Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Dermatology
  • 4.5.1. Dermatology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cryoablation Probe Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Cryoablation Probe Market: End Use Movement Analysis & Market Share, 2024 & 2030
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Specialty Clinics
  • 5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Ambulatory Surgery Center (ASC)
  • 5.5.1. Ambulatory Surgery Center (ASC) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cryoablation Probe Market: Regional Estimates & Trend Analysis

• 6.1. Regional Outlook
• 6.2. Cryoablation Probe Market: Regional Movement Analysis & Market Share, 2024 & 2030
• 6.3. North America
  • 6.3.1. North America Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Scenario
    • 6.3.2.4. Reimbursement Scenario
    • 6.3.2.5. U.S. Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Scenario
    • 6.3.3.4. Reimbursement Scenario
    • 6.3.3.5. Canada Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Scenario
    • 6.3.4.4. Reimbursement Scenario
    • 6.3.4.5. Mexico Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Scenario
    • 6.4.2.4. Reimbursement Scenario
    • 6.4.2.5. UK Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Scenario
    • 6.4.3.4. Reimbursement Scenario
    • 6.4.3.5. Germany Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Scenario
    • 6.4.4.4. Reimbursement Scenario
    • 6.4.4.5. France Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Scenario
    • 6.4.5.4. Reimbursement Scenario
    • 6.4.5.5. Italy Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Scenario
    • 6.4.6.4. Reimbursement Scenario
    • 6.4.6.5. Spain Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.7. Denmark
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Scenario
    • 6.4.7.4. Reimbursement Scenario
    • 6.4.7.5. Denmark Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Key Country Dynamics
    • 6.4.8.2. Competitive Scenario
    • 6.4.8.3. Regulatory Scenario
    • 6.4.8.4. Reimbursement Scenario
    • 6.4.8.5. Sweden Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.9. Norway
    • 6.4.9.1. Key Country Dynamics
    • 6.4.9.2. Competitive Scenario
    • 6.4.9.3. Regulatory Scenario
    • 6.4.9.4. Reimbursement Scenario
    • 6.4.9.5. Norway Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Scenario
    • 6.5.2.4. Reimbursement Scenario
    • 6.5.2.5. Japan Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Scenario
    • 6.5.3.4. Reimbursement Scenario
    • 6.5.3.5. China Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Scenario
    • 6.5.4.4. Reimbursement Scenario
    • 6.5.4.5. India Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. South Korea
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Scenario
    • 6.5.5.4. Reimbursement Scenario
    • 6.5.5.5. South Korea Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. Australia
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Scenario
    • 6.5.6.4. Reimbursement Scenario
    • 6.5.6.5. Australia Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. Thailand
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Scenario
    • 6.5.7.4. Reimbursement Scenario
    • 6.5.7.5. Thailand Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Latin America Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Scenario
    • 6.6.2.4. Reimbursement Scenario
    • 6.6.2.5. Brazil Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Scenario
    • 6.6.3.4. Reimbursement Scenario
    • 6.6.3.5. Argentina Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Middle East & Africa
  • 6.7.1. Middle East & Africa Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Scenario
    • 6.7.2.4. Reimbursement Scenario
    • 6.7.2.5. South Africa Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Scenario
    • 6.7.3.4. Reimbursement Scenario
    • 6.7.3.5. Saudi Arabia Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Scenario
    • 6.7.4.4. Reimbursement Scenario
    • 6.7.4.5. UAE Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Scenario
    • 6.7.5.4. Reimbursement Scenario
    • 6.7.5.5. Kuwait Cryoablation Probe Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Atricure, Inc
    • 7.2.1.1. Company Overview
    • 7.2.1.2. Financial Performance
    • 7.2.1.3. Product Benchmarking
    • 7.2.1.4. Strategic Initiatives
  • 7.2.2. Varian, A Siemens Healthineers Company
    • 7.2.2.1. Company Overview
    • 7.2.2.2. Financial Performance
    • 7.2.2.3. Product Benchmarking
    • 7.2.2.4. Strategic Initiatives
  • 7.2.3. Medtronic
    • 7.2.3.1. Company Overview
    • 7.2.3.2. Financial Performance
    • 7.2.3.3. Product Benchmarking
    • 7.2.3.4. Strategic Initiatives
  • 7.2.4. Metrum Cryoflex
    • 7.2.4.1. Company Overview
    • 7.2.4.2. Financial Performance
    • 7.2.4.3. Product Benchmarking
    • 7.2.4.4. Strategic Initiatives
  • 7.2.5. HealthTronics, Inc.
    • 7.2.5.1. Company Overview
    • 7.2.5.2. Financial Performance
    • 7.2.5.3. Product Benchmarking
    • 7.2.5.4. Strategic Initiatives
  • 7.2.6. Erbe Elektromedizin GmbH
    • 7.2.6.1. Company Overview
    • 7.2.6.2. Financial Performance
    • 7.2.6.3. Product Benchmarking
    • 7.2.6.4. Strategic Initiatives
  • 7.2.7. Keeler
    • 7.2.7.1. Company Overview
    • 7.2.7.2. Financial Performance
    • 7.2.7.3. Product Benchmarking
    • 7.2.7.4. Strategic Initiatives
  • 7.2.8. Boston Scientific Corporation
    • 7.2.8.1. Company Overview
    • 7.2.8.2. Financial Performance
    • 7.2.8.3. Product Benchmarking
    • 7.2.8.4. Strategic Initiatives
  • 7.2.9. Bruker
    • 7.2.9.1. Company Overview
    • 7.2.9.2. Financial Performance
    • 7.2.9.3. Product Benchmarking
    • 7.2.9.4. Strategic Initiatives
  • 7.2.10. IceCure Medical
    • 7.2.10.1. Company Overview
    • 7.2.10.2. Financial Performance
    • 7.2.10.3. Product Benchmarking
    • 7.2.10.4. Strategic Initiatives
• 7.3. Heat Map Analysis/ Company Market Position Analysis
• 7.4. Estimated Company Market Share Analysis, 2024